REDWOOD CITY, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective Nov. 5, 2021, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 177,500 shares of the common stock of the Company to newly hired employee with a per share exercise price of $17.81, the closing trading price on the grant date. One newly hired Vice President was granted options for 45,000 shares; eleven additional non-officer employees were granted options to purchase an aggregate of 132,500 shares.
Coherus BioSciences Announces New Employment Inducement Grants
Globe Newswire - Wed Nov 10, 2021
Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.